December 04, 2025 a 06:00 pm
PODD: Fundamental Ratio Analysis - Insulet Corporation
Insulet Corporation is positioned in the healthcare sector, particularly focusing on insulin delivery systems, which is a rapidly evolving market. The company has shown consistent growth driven by its innovative Omnipod System, appealing to those with insulin-dependent diabetes. With a varied geographical presence, Insulet Corporation stands as a key player with promising prospects, although potential regulatory changes and market competition pose risks.
Fundamental Rating
Insulet Corporation's fundamental rating is solid categorized mainly as 'B'. The overall score indicates moderate financial health.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 1 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 3 | |
| Price To Earnings | 1 | |
| Price To Book | 1 |
Historical Rating
The historical ratings show a stable progression in the company's performance scores over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-04 | 3 | 1 | 5 | 5 | 3 | 1 | 1 |
| Unknown | 0 | 1 | 5 | 5 | 3 | 1 | 1 |
Analyst Price Targets
Analysts have provided varied price targets for Insulet Corporation, presenting a consensus rating of 'Buy'.
| High | Low | Median | Consensus |
|---|---|---|---|
| $432 | $301 | $400 | $386.43 |
Analyst Sentiment
Current analyst sentiments indicate a strong inclination towards 'Buy' recommendations.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 31 | |
| Hold | 12 | |
| Sell | 2 | |
| Strong Sell | 0 |
Conclusion
Insulet Corporation shows potential backed by strong analyst recommendations and a promising position in the medical devices market. The company is driven by its innovative Omnipod System, although financial indicators like DCF and PE ratios indicate areas for improvement. With a global distribution network and a solid foothold in crucial markets, Insulet might offer growth opportunities, yet it faces challenges like market competition and regulatory dependencies.